This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Articles

Drug Accountability And Destruction Reporting

Closing The Clinical Supply Chain Information Loop

Lack of accurate accountability logs at the end of a clinical study can trigger warning letters from regulators, delaying or even eliminating acceptance of trial data from a non-conforming site.This in turn can delay trial completion and subsequent product approvals, which carries significant costs in terms of lost opportunities…

Read more about this here

October 12, 2015


$12M Investment to Expand Tredegar Manufacturing Capabilities

Doubles Capacity at Leading Edge Facility to Support Business Growth PCI Pharma Services is today pleased to announce that we... View Article

PCI Pharma Services Completes Expansion of its Specialty Drug Product Capabilities at Rockford, IL Site

Increases Capacity at State-of-the-Art Facility in Response to Growing Market Needs PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading pharmaceutical and... View Article

x